These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
477 related articles for article (PubMed ID: 17395343)
1. Evaluating rotavirus vaccination in England and Wales. Part I. Estimating the burden of disease. Harris JP; Jit M; Cooper D; Edmunds WJ Vaccine; 2007 May; 25(20):3962-70. PubMed ID: 17395343 [TBL] [Abstract][Full Text] [Related]
2. Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination. Jit M; Edmunds WJ Vaccine; 2007 May; 25(20):3971-9. PubMed ID: 17400341 [TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales. Atkins KE; Shim E; Carroll S; Quilici S; Galvani AP Vaccine; 2012 Nov; 30(48):6766-76. PubMed ID: 23000223 [TBL] [Abstract][Full Text] [Related]
4. An economic analysis of rotavirus vaccination in Italy. Giammanco MD; Coniglio MA; Pignato S; Giammanco G Vaccine; 2009 Jun; 27(29):3904-11. PubMed ID: 19446934 [TBL] [Abstract][Full Text] [Related]
5. An update to "The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe". Jit M; Mangen MJ; Melliez H; Yazdanpanah Y; Bilcke J; Salo H; Edmunds WJ; Beutels P Vaccine; 2010 Nov; 28(47):7457-9. PubMed ID: 20846529 [TBL] [Abstract][Full Text] [Related]
6. Burden of paediatric rotavirus gastroenteritis and potential benefits of a universal rotavirus vaccination programme with RotaTeq in France. Huet F; Largeron N; Trichard M; Miadi-Fargier H; Jasso-Mosqueda G Vaccine; 2007 Aug; 25(34):6348-58. PubMed ID: 17629598 [TBL] [Abstract][Full Text] [Related]
7. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Payne DC; Staat MA; Edwards KM; Szilagyi PG; Gentsch JR; Stockman LJ; Curns AT; Griffin M; Weinberg GA; Hall CB; Fairbrother G; Alexander J; Parashar UD Pediatrics; 2008 Dec; 122(6):1235-43. PubMed ID: 19047240 [TBL] [Abstract][Full Text] [Related]
8. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam. Fischer TK; Anh DD; Antil L; Cat ND; Kilgore PE; Thiem VD; Rheingans R; Tho le H; Glass RI; Bresee JS J Infect Dis; 2005 Nov; 192(10):1720-6. PubMed ID: 16235169 [TBL] [Abstract][Full Text] [Related]
9. Impact of the national rotavirus vaccination programme on acute gastroenteritis in England and associated costs averted. Thomas SL; Walker JL; Fenty J; Atkins KE; Elliot AJ; Hughes HE; Stowe J; Ladhani S; Andrews NJ Vaccine; 2017 Jan; 35(4):680-686. PubMed ID: 28007397 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland. Tilson L; Jit M; Schmitz S; Walsh C; Garvey P; McKeown P; Barry M Vaccine; 2011 Oct; 29(43):7463-73. PubMed ID: 21821085 [TBL] [Abstract][Full Text] [Related]
11. Impact of rotavirus vaccination on epidemiological dynamics in England and Wales. Atkins KE; Shim E; Pitzer VE; Galvani AP Vaccine; 2012 Jan; 30(3):552-64. PubMed ID: 22133508 [TBL] [Abstract][Full Text] [Related]
12. Rotavirus disease burden, Nicaragua 2001-2005: defining the potential impact of a rotavirus vaccination program. Amador JJ; Vasquez J; Orozco M; Pedreira C; Malespin O; De Oliveira LH; Tate J; Parashar U; Patel M Int J Infect Dis; 2010 Jul; 14(7):e592-5. PubMed ID: 20022778 [TBL] [Abstract][Full Text] [Related]
13. Potential impact and cost-effectiveness analysis of rotavirus vaccination of children in Israel. Chodick G; Waisbourd-Zinman O; Shalev V; Kokia E; Rabinovich M; Ashkenazi S Eur J Public Health; 2009 Jun; 19(3):254-9. PubMed ID: 19221026 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and "no medical care'' disease impact in Belgium. Bilcke J; Van Damme P; Beutels P Med Decis Making; 2009; 29(1):33-50. PubMed ID: 18948433 [TBL] [Abstract][Full Text] [Related]
15. Projected Impact of the new rotavirus vaccination program on hospitalizations for gastroenteritis and rotavirus disease among US children <5 years of age during 2006-2015. Curns AT; Coffin F; Glasser JW; Glass RI; Parashar UD J Infect Dis; 2009 Nov; 200 Suppl 1():S49-56. PubMed ID: 19817614 [TBL] [Abstract][Full Text] [Related]
16. Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study. Van Damme P; Giaquinto C; Huet F; Gothefors L; Maxwell M; Van der Wielen M; J Infect Dis; 2007 May; 195 Suppl 1():S4-S16. PubMed ID: 17387650 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of rotavirus vaccination programs in Taiwan. Chang WC; Yen C; Chi CL; Wu FT; Huang YC; Lin JS; Huang FC; Tate JE; Wu HS; Hsiung CA Vaccine; 2013 Nov; 31(46):5458-65. PubMed ID: 24060569 [TBL] [Abstract][Full Text] [Related]
18. Costs of community-acquired pediatric rotavirus gastroenteritis in 7 European countries: the REVEAL Study. Giaquinto C; Van Damme P; Huet F; Gothefors L; Van der Wielen M; J Infect Dis; 2007 May; 195 Suppl 1():S36-S44. PubMed ID: 17539193 [TBL] [Abstract][Full Text] [Related]
19. Budget impact and cost-effectiveness of including a pentavalent rotavirus vaccine in the New Zealand childhood immunization schedule. Milne RJ; Grimwood K Value Health; 2009 Sep; 12(6):888-98. PubMed ID: 19490550 [TBL] [Abstract][Full Text] [Related]
20. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries. Rheingans RD; Antil L; Dreibelbis R; Podewils LJ; Bresee JS; Parashar UD J Infect Dis; 2009 Nov; 200 Suppl 1():S16-27. PubMed ID: 19817595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]